Researchers Say Not All A-Fib Patients Need Anticoagulation

Share this content:
Researchers Say Not All A-Fib Patients Need Anticoagulation
Researchers Say Not All A-Fib Patients Need Anticoagulation

TUESDAY, Oct. 18, 2016 (HealthDay News) -- Some patients with atrial fibrillation who have implanted pacemakers or defibrillators may not always need anticoagulation, according to a study published online Oct. 17 in Circulation.

Steven Swiryn, M.D., a clinical professor of cardiology at the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues looked at 37,531 electrograms from 5,379 patients over two years. All the participants took part in the RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes), an ongoing study that follows patients with pacemakers or defibrillators.

The researchers found that patients who had only short bouts of atrial fibrillation -- estimated at 20 seconds or less -- were at no more risk for stroke or other cardiovascular complications than patients without atrial fibrillation.

"We knew that people with atrial fibrillation are at higher risk of stroke, but the next question was, how much atrial fibrillation?" Swiryn said in a news release from the American Heart Association. "Other studies have shown that prolonged episodes of atrial fibrillation pose a risk, but what about short ones? The answer until this study was 'no one knows.' Now we have good solid data that if all you have is short episodes of atrial fibrillation, the risk is so low that it doesn't warrant anticoagulants."

Several authors disclosed financial ties to pharmaceutical and medical device companies, including St. Jude Medical, which funded the RATE Registry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

60 Percent of Adults Report Adverse Childhood Experiences

>60 Percent of Adults Report Adverse Childhood Experiences

Higher ACE exposures for black, Hispanic, multiracial individuals, those with below high school education

Few Yogurt Products Qualify As Low-Sugar

Few Yogurt Products Qualify As Low-Sugar

Only two of 101 children's yogurt and fromage frais products had ≤5 g sugar/100 g of product

Allopurinol Dose Escalation for Gout Doesn't Improve Mortality

Allopurinol Dose Escalation for Gout Doesn't Improve Mortality

Linked to small increase in mortality; at 2 years, 31 percent of dose escalators achieved serum urate goal

is free, fast, and customized just for you!




Already a member?

Sign In Now »